Category: Genetics
Don’t Worry About Designer Babies – gene editing won’t work on complex traits like intelligence
Despite the successes in gene discovery of the past 10 years, our knowledge of the combined contribution of all genetic variants is too limited for embryo editing.
Why treat gene editing differently in two types of human cells?
At the conclusion of the recent International Summit on Human Gene Editing in Washington, DC, its organizing committee released a much-anticipated statement recommending how human genetic engineering should be regulated.
Event Review: International Summit on Gene Editing
On December 1st – December 3rd 2015, the main scientific body of the United States, that is, the National Academies, held the first international summit on gene editing.
Video: International Summit on Human Gene Editing
A major component of the National Academy of Sciences and the National Academy of Medicine’s Human Gene-Editing Initiative is an international summit to take place December 1-3 in Washington, D.C. Co-hosted with the Chinese Academy of Sciences and the U.K.’s Royal Society,...
Is Peer Review Delaying Anti-Aging Research?
Ten years ago, a team lead by Irina Conboy at the University of California at Berkeley showed something remarkable: if you take old cells and put them in a young environment, you effectively rejuvenate them.
Transgenic Mice Humanized FoxP2 and the Timing of Habits
Schreiweis et al. have tested transgenic mice in which the mouse version of the language-related gene FoxP2 was replaced with the human version.
Video Friday: Dr. Jeffrey Bland Talks With BioViva CEO Elizabeth Parrish
Elizabeth Parrish is the CEO of BioViva, a biotech company in the Seattle area that is focused on developing gene therapies that may one day mitigate the diseases of aging.
Chemistry Nobel Prize — DNA research lays foundation for new ways to fight cancer
My lab is interested in understanding how the DNA damage response is regulated specifically at telomeric DNA.